candesartan cilexetil has been researched along with Lung Neoplasms in 1 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
Lung Neoplasms: Tumors or cancer of the LUNG.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X | 1 |
| Yang, X | 1 |
| Mao, F | 1 |
| Wei, J | 1 |
| Xu, Y | 1 |
| Li, B | 1 |
| Zhu, J | 1 |
| Ni, S | 1 |
| Jia, L | 1 |
| Li, J | 1 |
1 other study available for candesartan cilexetil and Lung Neoplasms
| Article | Year |
|---|---|
Development of novel benzimidazole-derived neddylation inhibitors for suppressing tumor growth invitro and invivo.
Topics: A549 Cells; Animals; Antineoplastic Agents; Benzimidazoles; Cell Proliferation; Female; Humans; Lung | 2021 |